Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning

IntroductionLactylation, a post-translational modification characterized by the attachment of lactate to protein lysine residues on proteins, plays a pivotal role in cancer progression and immune evasion. However, its implications in immunity regulation and prostate cancer prognosis remains poorly u...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenghao Zhou, Lifeng Ding, Huailan Wang, Gonghui Li, Lei Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1634985/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342866507169792
author Chenghao Zhou
Lifeng Ding
Huailan Wang
Gonghui Li
Lei Gao
author_facet Chenghao Zhou
Lifeng Ding
Huailan Wang
Gonghui Li
Lei Gao
author_sort Chenghao Zhou
collection DOAJ
description IntroductionLactylation, a post-translational modification characterized by the attachment of lactate to protein lysine residues on proteins, plays a pivotal role in cancer progression and immune evasion. However, its implications in immunity regulation and prostate cancer prognosis remains poorly understood. This study aims to systematically examine the impact of lactylation-related genes (LRGs) on prostate cancer.MethodsSingle-cell and bulk RNA sequencing data from patients with prostate cancer were analyzed. Data were sourced from TCGA-PRAD, GSE116918, and GSE54460, with batch effects mitigated using the ComBat method. LRGs were identified from exisiting literature, and unsupervised clustering was applied to assess their prognostic siginificance. The tumor microenvironment and functional enrichment of relevant pathways were also evaluated. A prognostic model was developed using integrative machine learning techniques, with drug sensitivy analysis included. The mRNA expression profiles of the top ten genes were validated in clinical samples.ResultsSingle-cell RNA sequencing revealed distinct lactylation signatures across various cell types. Bulk RNA-seq analysis identified 56 prognostic LRGs, classifying patients into two distinct clusters with divergent prognoses. The high-risk cluster exhibited reduced immune cell infiltration and increased resistance to specific targeted therapies. A machine learning-based prognostic signature was developed, demonstrating robust predictive accuracy for treatment responses and disease outcomes.ConclusionThis study offers a comprehensive analysis of lactylation in prostate cancer, identifying potential prognostic biomarkers. The proposed prognostic signature provides a novel approach to personalized treatment strategies, deepening our understanding of the molecular mechanisms driving prostate cancer and offering a tool for predicting therapeutic responses and clinical outcomes.
format Article
id doaj-art-bebd5aa3b2f340c8b0f764d901816dfc
institution Kabale University
issn 1663-9812
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-bebd5aa3b2f340c8b0f764d901816dfc2025-08-20T03:43:14ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-08-011610.3389/fphar.2025.16349851634985Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learningChenghao ZhouLifeng DingHuailan WangGonghui LiLei GaoIntroductionLactylation, a post-translational modification characterized by the attachment of lactate to protein lysine residues on proteins, plays a pivotal role in cancer progression and immune evasion. However, its implications in immunity regulation and prostate cancer prognosis remains poorly understood. This study aims to systematically examine the impact of lactylation-related genes (LRGs) on prostate cancer.MethodsSingle-cell and bulk RNA sequencing data from patients with prostate cancer were analyzed. Data were sourced from TCGA-PRAD, GSE116918, and GSE54460, with batch effects mitigated using the ComBat method. LRGs were identified from exisiting literature, and unsupervised clustering was applied to assess their prognostic siginificance. The tumor microenvironment and functional enrichment of relevant pathways were also evaluated. A prognostic model was developed using integrative machine learning techniques, with drug sensitivy analysis included. The mRNA expression profiles of the top ten genes were validated in clinical samples.ResultsSingle-cell RNA sequencing revealed distinct lactylation signatures across various cell types. Bulk RNA-seq analysis identified 56 prognostic LRGs, classifying patients into two distinct clusters with divergent prognoses. The high-risk cluster exhibited reduced immune cell infiltration and increased resistance to specific targeted therapies. A machine learning-based prognostic signature was developed, demonstrating robust predictive accuracy for treatment responses and disease outcomes.ConclusionThis study offers a comprehensive analysis of lactylation in prostate cancer, identifying potential prognostic biomarkers. The proposed prognostic signature provides a novel approach to personalized treatment strategies, deepening our understanding of the molecular mechanisms driving prostate cancer and offering a tool for predicting therapeutic responses and clinical outcomes.https://www.frontiersin.org/articles/10.3389/fphar.2025.1634985/fullprostate cancerlactylationprognostic biomarkermachine learningpersonalized treatmentimmune microenvironment
spellingShingle Chenghao Zhou
Lifeng Ding
Huailan Wang
Gonghui Li
Lei Gao
Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning
Frontiers in Pharmacology
prostate cancer
lactylation
prognostic biomarker
machine learning
personalized treatment
immune microenvironment
title Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning
title_full Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning
title_fullStr Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning
title_full_unstemmed Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning
title_short Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-seq and machine learning
title_sort integrative analysis of lactylation related genes in prostate cancer unveiling heterogeneity through single cell rna seq bulk rna seq and machine learning
topic prostate cancer
lactylation
prognostic biomarker
machine learning
personalized treatment
immune microenvironment
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1634985/full
work_keys_str_mv AT chenghaozhou integrativeanalysisoflactylationrelatedgenesinprostatecancerunveilingheterogeneitythroughsinglecellrnaseqbulkrnaseqandmachinelearning
AT lifengding integrativeanalysisoflactylationrelatedgenesinprostatecancerunveilingheterogeneitythroughsinglecellrnaseqbulkrnaseqandmachinelearning
AT huailanwang integrativeanalysisoflactylationrelatedgenesinprostatecancerunveilingheterogeneitythroughsinglecellrnaseqbulkrnaseqandmachinelearning
AT gonghuili integrativeanalysisoflactylationrelatedgenesinprostatecancerunveilingheterogeneitythroughsinglecellrnaseqbulkrnaseqandmachinelearning
AT leigao integrativeanalysisoflactylationrelatedgenesinprostatecancerunveilingheterogeneitythroughsinglecellrnaseqbulkrnaseqandmachinelearning